CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Clinical trial NCT03934840 · COMPLETED

Trial details

NCT number: NCT03934840
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2019-10-10
Primary completion: 2023-06-19
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.